Literature DB >> 10930443

In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.

T J Kelley1, H L Elmer.   

Abstract

Inducible nitric oxide synthase-2 (NOS2) expression has been shown to be reduced in cystic fibrosis (CF) epithelial cells. Reduced NOS2 expression is unexpected, given the inflammatory nature of CF airway disease, and is an indication that cell-signaling mechanisms necessary for proper NOS2 regulation are probably altered in CF epithelium. Therefore, we examined the expression levels of regulatory factors necessary for NOS2 expression in CF epithelium and showed that IFN regulatory factor-1 (IRF-1) is necessary for full NOS2 expression. Mice lacking IRF-1 expression have diminished epithelial NOS2 expression, as well as reduced NO-dependent chloride transport across the nasal epithelia. Furthermore, IRF-1 protein expression is reduced in nasal and intestinal epithelial cells from CF mice, suggesting a possible mechanism for the CF-related reduction of epithelial NOS2 expression. Active signal transducer and activator of transcription-1 (Stat1) is necessary for both NOS2 and IRF-1 expression. We found that protein levels of Stat1 were increased in CF cells, but that the active phosphorylated form of Stat1 was bound to the protein inhibitor of activated Stat1 (PIAS1). We propose that increased levels of PIAS1 diminish certain cell-signaling pathways, resulting in reduced IRF-1 and NOS2 expression in CF epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930443      PMCID: PMC314327          DOI: 10.1172/JCI9560

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.

Authors:  M Saura; C Zaragoza; C Bao; A McMillan; C J Lowenstein
Journal:  J Mol Biol       Date:  1999-06-11       Impact factor: 5.469

2.  Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression.

Authors:  W K Steagall; H L Elmer; K G Brady; T J Kelley
Journal:  Am J Respir Cell Mol Biol       Date:  2000-01       Impact factor: 6.914

3.  Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis.

Authors:  A Kroesbergen; Q Jöbsis; E H Bel; W C Hop; J C de Jongste
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

4.  Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro.

Authors:  O Tabary; J M Zahm; J Hinnrasky; J P Couetil; P Cornillet; M Guenounou; D Gaillard; E Puchelle; J Jacquot
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Nitric oxide-mediated regulation of transepithelial sodium and chloride transport in murine nasal epithelium.

Authors:  H L Elmer; K G Brady; M L Drumm; T J Kelley
Journal:  Am J Physiol       Date:  1999-03

6.  Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung.

Authors:  H A Jaffe; R Buhl; A Mastrangeli; K J Holroyd; C Saltini; D Czerski; H S Jaffe; S Kramer; S Sherwin; R G Crystal
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice.

Authors:  B R Grubb; R N Vick; R C Boucher
Journal:  Am J Physiol       Date:  1994-05

8.  Dietary changes improve survival of CFTR S489X homozygous mutant mouse.

Authors:  E A Eckman; C U Cotton; D M Kube; P B Davis
Journal:  Am J Physiol       Date:  1995-11

9.  Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.

Authors:  C A Salkowski; S A Barber; G R Detore; S N Vogel
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR.

Authors:  L Zhou; C R Dey; S E Wert; M D DuVall; R A Frizzell; J A Whitsett
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

View more
  19 in total

1.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  Genetic variation and clinical heterogeneity in cystic fibrosis.

Authors:  Mitchell L Drumm; Assem G Ziady; Pamela B Davis
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

3.  β-arrestin-2 regulation of the cAMP response element binding protein.

Authors:  Mary E Manson; Deborah A Corey; Sharon M Rymut; Thomas J Kelley
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

Review 4.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

5.  Genomewide association analysis of respiratory syncytial virus infection in mice.

Authors:  James M Stark; M Michael Barmada; Abby V Winterberg; Nilanjana Majumber; William J Gibbons; Marilyn A Stark; Maureen A Sartor; Mario Medvedovic; Jay Kolls; Kiflai Bein; Beena Mailaparambil; Marcus Krueger; Andrea Heinzmann; George D Leikauf; Daniel R Prows
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

6.  Regulation of airway tight junctions by proinflammatory cytokines.

Authors:  Carolyn B Coyne; Miriam K Vanhook; Todd M Gambling; Johnny L Carson; Richard C Boucher; Larry G Johnson
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

7.  High-content functional screen to identify proteins that correct F508del-CFTR function.

Authors:  Agata M Trzcinska-Daneluti; Diane Ly; Lise Huynh; Chong Jiang; Christopher Fladd; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2008-12-15       Impact factor: 5.911

8.  cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells.

Authors:  Mary E Manson; Deborah A Corey; Nicole M White; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

Review 9.  Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.

Authors:  David Nichols; James Chmiel; Melvin Berger
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 10.  Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Authors:  David P Nichols; Michael W Konstan; James F Chmiel
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.